A randomised placebo-controlled clinical trial on the efficacy of local lidocaine injections and oral citalopram for the treatment of complex regional pain syndrome

被引:3
作者
Fallico, Nefer [1 ,2 ]
Padmanabhan, Rahul [3 ]
Rahman, Shakeel [2 ]
Somma, Francesco [1 ]
Spagnoli, Anna Maria [1 ]
机构
[1] Sapienza Univ Rome, Dept Plast & Reconstruct Surg, Rome, Italy
[2] Guys & St Thomas Hosp, Dept Plast Surg, London, England
[3] Kings Coll London, GKT Sch Med Educ, London, England
关键词
CRPS; Citalopram; Local lidocaine injections; Therapeutic protocol; SYNDROME TYPE-I; REFLEX SYMPATHETIC DYSTROPHY; PERIPHERAL NEUROPATHIC PAIN; DIAGNOSTIC-CRITERIA; INFUSION; IMPAIRMENT; GUIDELINES;
D O I
10.1016/j.bjps.2021.11.022
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Complex regional pain syndrome (CRPS) is a neuropathic pain condition with no universally recognised treatment. The study evaluates the efficacy of a therapeutic protocol consisting of oral citalopram and lidocaine injections in patients affected by CRPS. Methods: Between January 2010 and December 2014, 150 consecutive patients with CRPS were enrolled in the study and randomly assigned into three groups: group one - lidocaine injection and oral citalopram; group two - lidocaine injection and oral placebo; and group three - injective and oral placebo. The Impairment Sum Score (ISS) was used to assess the severity of CRPS before, as well as at regular intervals after treatment commenced. Statistical significance ( p < 0.05) was determined by paired t -tests. Results: The combined treatment proved to be more effective (ISS 47.6 to 12.6) than local anaesthetic alone (ISS 47.5 to 21.5) and to placebo (ISS 47.2 to 29.9). Conclusion: This study indicates that CRPS may be managed with well-tolerated association of oral citalopram and lidocaine injections. (c) 2021 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:970 / 979
页数:10
相关论文
共 42 条
[1]  
[Anonymous], 2002, AUS MUSCULOSKELETAL
[2]  
Baltenberger EP., 2015, Ment Health Clin, V5, P123, DOI [10.9740/mhc.2015.05.123, DOI 10.9740/MHC.2015.05.123]
[3]  
Baron R, 1999, MUSCLE NERVE, V22, P678, DOI 10.1002/(SICI)1097-4598(199906)22:6<678::AID-MUS4>3.0.CO
[4]  
2-P
[5]   Extent of recovery in the first 12 months of complex regional pain syndrome type-1: A prospective study [J].
Bean, D. J. ;
Johnson, M. H. ;
Heiss-Dunlop, W. ;
Kydd, R. R. .
EUROPEAN JOURNAL OF PAIN, 2016, 20 (06) :884-894
[6]   A randomized controlled trial of amitriptyline versus gabapentin for complex regional pain syndrome type I and neuropathic pain in children [J].
Brown, Stephen ;
Johnston, Bradley ;
Amaria, Khush ;
Watkins, Jessica ;
Campbell, Fiona ;
Pehora, Carolyne ;
McGrath, Patricia .
SCANDINAVIAN JOURNAL OF PAIN, 2016, 13 :156-163
[7]   An Update on the Pathophysiology of Complex Regional Pain Syndrome [J].
Bruehl, Stephen .
ANESTHESIOLOGY, 2010, 113 (03) :713-725
[8]   Painful swelling after a noxious event and the development of complex regional pain syndrome 1: A one-year prospective study [J].
Brunner, F. ;
Bachmann, L. M. ;
Perez, R. S. G. M. ;
Marinus, J. ;
Wertli, M. M. .
EUROPEAN JOURNAL OF PAIN, 2017, 21 (09) :1611-1617
[9]   5% Lidocaine-medicated plaster for the treatment of chronic peripheral neuropathic pain: complex regional pain syndrome and other neuropathic conditions [J].
Calderon, Enrique ;
Eloisa Calderon-Seoane, Maria ;
Garcia-Hernandez, Rafael ;
Miguel Torres, Luis .
JOURNAL OF PAIN RESEARCH, 2016, 9 :763-770
[10]   Local anaesthetic systemic toxicity [J].
Christie, Linsey E. ;
Picard, John ;
Weinberg, Guy L. .
BJA EDUCATION, 2015, 15 (03) :136-142